CA199 Gastrointestinal Cancer Antigen Monoclonal Antibody

Name: CA199 Gastrointestinal Cancer Antigen Monoclonal Antibody
Brand: Auker Biotech Co., Ltd.
SKU: 1931240711

Hubei, ChinaAuker Biotech Co., Ltd.

US$280.00

1-99 mg

US$180.00

100-999 mg

US$100.00

1,000+ mg

Sample price:US$100.00/mg.Request sample

Product profile

Customization

Available

Supply Type

OBM(Original Brand Manufacturing)

Usage Mode

For external use

Model NO.

antibody

Suitable for

Elderly, Adult

Type

Antibody, Antigen

Application

for Diagnosis

Form

Liquid

Storage

cool or freezer as per COA instruction

Shelf life

2 years

Purity

96%

Delivery time

3-5 days

Application Platform

ELISA

Transport Package

Bottle

Specification

1mg/bottle

Trademark

Aoke Botai

Origin

China

HS Code

3002130090

Production Capacity

10g/Month

Company profile

Auker Biotech Co., Ltd.

Hubei, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2020-04-30Nearest Port: Wuhan, ShanghaiAverage Response Time: ≤9.50hTerms of Payment: T/T, PayPal, Western UnionInternational Commercial Terms(Incoterms): FOB, EXW, CIF

AI-Powered supplier vetting

SummaryAuker Biotech Co., Ltd., based in Wuhan, China, is a high-tech manufacturer and trading company in the healthcare and chemical sectors. Established in 2002, the company specializes in in vitro diagnostic raw materials and has developed strong innovation capabilities with notable technology platforms. Certified under ISO 9001 and ISO 13485, it exports to various global markets, generating 31-40% of sales from exports. The company operates three production lines and offers customization services. Financial data is not provided to assess credibility, and customer cases are limited.

Supplier typeAuker Biotech Co., Ltd. is a manufacturer and trading company specializing in biotechnology products, operating as a limited company in Wuhan, China.

CertificationsThe company holds ISO 9001 and ISO 13485 certifications, indicating compliance with international quality standards.

R&D capabilityAuker Biotech has developed advanced technology platforms in monoclonal antibodies and recombinant proteins, indicating strong innovation capabilities.

Production capacityThe company operates three production lines and maintains a lead time of 15 workdays even during peak seasons, indicating robust production capabilities.

Customization capabilityThe company provides customized services for monoclonal antibodies and recombinant proteins, showing strong customization capabilities.